(Q39778425)

14 September 2017

Proteasome inhibition with bortezomib suppresses growth and induces apoptosis in osteosarcoma (English)

1 reference

14 September 2017

0 references

Yuriy Shapovalov

1

1 reference

14 September 2017

David Benavidez

series ordinal

2

1 reference

14 September 2017

Daniel Zuch

series ordinal

3

1 reference

14 September 2017

Roman A Eliseev

series ordinal

4

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

International Journal of Cancer

14 September 2017

1 reference

14 September 2017

127

1 reference

14 September 2017

67-76

1 reference

14 September 2017

1

1 reference

Biology and therapeutic advances for pediatric osteosarcoma

14 September 2017

1 reference

Primary bone osteosarcoma in the pediatric age: state of the art.

21 January 2018

1 reference

State-of-the-art approach in selective curable tumors: bone sarcoma

21 January 2018

1 reference

Expression of osteocalcin and its transcriptional regulators core-binding factor alpha 1 and MSX2 in osteoid-forming tumours

21 January 2018

1 reference

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

21 January 2018

1 reference

The logic of TGFbeta signaling.

21 January 2018

1 reference

AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis

21 January 2018

1 reference

Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons

21 January 2018

1 reference

t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1

21 January 2018

1 reference

Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma

21 January 2018

1 reference

Causal relationship between the loss of RUNX3 expression and gastric cancer

21 January 2018

1 reference

The RUNX genes: gain or loss of function in cancer

21 January 2018

1 reference

Runx2-mediated activation of the Bax gene increases osteosarcoma cell sensitivity to apoptosis.

21 January 2018

1 reference

The Bcl2 family: regulators of the cellular life-or-death switch

21 January 2018

1 reference

Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation

21 January 2018

1 reference

Cyclin D1-cdk4 induce runx2 ubiquitination and degradation

21 January 2018

1 reference

Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3.

21 January 2018

1 reference

Caspase structure, proteolytic substrates, and function during apoptotic cell death

21 January 2018

1 reference

An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis

21 January 2018

1 reference

Critical role of notch signaling in osteosarcoma invasion and metastasis

21 January 2018

1 reference

Development and characterization of a conditionally immortalized human fetal osteoblastic cell line

21 January 2018

1 reference

Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma.

21 January 2018

1 reference

Cbfa1 isoforms exert functional differences in osteoblast differentiation

21 January 2018

1 reference

Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia

21 January 2018

1 reference

Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors

21 January 2018

1 reference

Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells

21 January 2018

1 reference

Phosphorylation, acetylation and ubiquitination: the molecular basis of RUNX regulation

21 January 2018

1 reference

Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease.

21 January 2018

1 reference

Targeting the ubiquitin-proteasome system for cancer therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25024

1 reference

release_ag6ba4q64vdcnkko5snqnvptou

14 September 2017

0 references

1 reference